SUBSCRIBE
SUBSCRIBE
News   FDA

Akorn-Strides, LLC Announces FDA Approval for Rifampin for Injection USP, 600 mg/Vial

May 23, 2008 | 
1 min read
BUFFALO GROVE, Ill.--(BUSINESS WIRE)--Akorn-Strides, LLC today announced the approval of an ANDA for Rifampin for Injection USP, 600 mg/vial. This is the first lyophilized Injectable product approval for the Joint Venture.
FDA Approvals
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
halftone magazine style banner, dislike, negative rating, hand thumbs down
FDA
FDA Drops Another Cache of Heavily Redacted Rejection Letters, Promises Future ‘Real-Time’ Access
September 4, 2025
 · 
4 min read
 · 
Annalee Armstrong
Washington, D.C., USA- January 13, 2020: FDA Sign at its headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.
Regulatory
‘All Wrapper, No Gift’: FDA Releases New Rare Disease Approval Framework
September 4, 2025
 · 
2 min read
 · 
Tristan Manalac
Vaccines
Prasad Signals Steeper Requirements for COVID-19 Vaccines
September 3, 2025
 · 
3 min read
 · 
Tristan Manalac
FDA
Offit Out at FDA Vaccine Advisory Committee After HHS Rebuff
September 2, 2025
 · 
3 min read
 · 
Heather McKenzie